158 related articles for article (PubMed ID: 36519606)
1. Neutrophil‑to‑lymphocyte ratio as a marker of inflammation in restless legs syndrome during pregnancy.
Karadeniz M; Ser MH; Nalbantoglu M; Tumay FB; Yilmaz N; Acikgoz S; Senel GB
Bratisl Lek Listy; 2023; 124(1):42-46. PubMed ID: 36519606
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy.
Neyal A; Senel GB; Aslan R; Nalbantoglu M; Acikgoz S; Yilmaz N; Tumay FB; Neyal M; Karadeniz D
Sleep Med; 2015 Sep; 16(9):1036-40. PubMed ID: 26298776
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning.
Pienczk-Ręcławowicz K; Pilarska E; Olszewska A; Ręcławowicz D; Konieczna S; Sławek J
Sleep Med; 2022 Jan; 89():48-54. PubMed ID: 34883398
[TBL] [Abstract][Full Text] [Related]
4. Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression.
Wesström J; Skalkidou A; Manconi M; Fulda S; Sundström-Poromaa I
J Clin Sleep Med; 2014 May; 10(5):527-33. PubMed ID: 24812538
[TBL] [Abstract][Full Text] [Related]
5. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation.
Picchietti DL; Hensley JG; Bainbridge JL; Lee KA; Manconi M; McGregor JA; Silver RM; Trenkwalder C; Walters AS;
Sleep Med Rev; 2015 Aug; 22():64-77. PubMed ID: 25553600
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and quality of life and sleep in children and adolescents with restless legs syndrome/Willis-Ekbom disease.
Sander HH; Eckeli AL; Costa Passos AD; Azevedo L; Fernandes do Prado LB; França Fernandes RM
Sleep Med; 2017 Feb; 30():204-209. PubMed ID: 28215250
[TBL] [Abstract][Full Text] [Related]
7. Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia.
Kolukisa M; Soysal P; Gületkin TÖ; Karatoprak C; Bilgen HR; Gürsoy AE
Ideggyogy Sz; 2016 Sep; 69(9-10):356-360. PubMed ID: 29638100
[TBL] [Abstract][Full Text] [Related]
8. Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome.
Varım C; Acar BA; Uyanık MS; Acar T; Alagoz N; Nalbant A; Kaya T; Ergenc H
Singapore Med J; 2016 Sep; 57(9):514-6. PubMed ID: 27662970
[TBL] [Abstract][Full Text] [Related]
9. Restless legs syndrome in pediatric onset multiple sclerosis.
Yalcinkaya BC; Amirov CB; Saltik S; Senel GB
Mult Scler Relat Disord; 2021 Nov; 56():103295. PubMed ID: 34624645
[TBL] [Abstract][Full Text] [Related]
10. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
11. Living with Restless Legs Syndrome/Willis-Ekbom Disease.
Tachibana N
Sleep Med Clin; 2015 Sep; 10(3):359-67, xv. PubMed ID: 26329446
[TBL] [Abstract][Full Text] [Related]
12. Willis-Ekbom Disease or Restless Legs Syndrome?
Carlos K; Prado LB; Carvalho LB; Prado GF
Sleep Med; 2015 Sep; 16(9):1156-9. PubMed ID: 26298794
[TBL] [Abstract][Full Text] [Related]
13. Which Factors in Spinocerebellar Ataxia Type 3 Patients Are Associated with Restless Legs Syndrome/Willis-Ekbom Disease?
Gitaí LLG; Éckeli AL; Sobreira-Neto MA; Diniz PRB; Santos AC; Júnior WM; Fernandes RMF
Cerebellum; 2021 Feb; 20(1):21-30. PubMed ID: 32946033
[TBL] [Abstract][Full Text] [Related]
14. Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
Allen RP
Int Rev Psychiatry; 2014 Apr; 26(2):248-62. PubMed ID: 24892899
[TBL] [Abstract][Full Text] [Related]
15. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
[TBL] [Abstract][Full Text] [Related]
16. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
Silber MH; Becker PM; Earley C; Garcia-Borreguero D; Ondo WG;
Mayo Clin Proc; 2013 Sep; 88(9):977-86. PubMed ID: 24001490
[TBL] [Abstract][Full Text] [Related]
17. Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.
Rinaldi F; Galbiati A; Marelli S; Cusmai M; Gasperi A; Oldani A; Zucconi M; Padovani A; Ferini Strambi L
J Neurol; 2016 Feb; 263(2):396-402. PubMed ID: 26725086
[TBL] [Abstract][Full Text] [Related]
18. Association of BST1 polymorphism with idiopathic restless legs syndrome in Chinese population.
Huang Y; Wang P; Luo Q; Ma J
Sleep Breath; 2021 Dec; 25(4):1987-1993. PubMed ID: 33625657
[TBL] [Abstract][Full Text] [Related]
19. Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.
Stevens MS
Sleep Med Clin; 2015 Sep; 10(3):369-73, xv-xvi. PubMed ID: 26329447
[TBL] [Abstract][Full Text] [Related]
20. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
